Single enzyme with the power of three could offer shortcut to therapeutic target

Researchers identified a single enzyme doing the work of a trio thought necessary to control a common cellular signaling process being pursued as a therapeutic target. The work was done through a study of Legionella pneumophila, the bacterium that causes Legionnaires' disease.